NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – A new biomarker – tumor-associated CD68+ macrophages — predicts poor outcomes in patients with classic Hodgkin’s lymphoma, new research indicates. About 20% of…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
NEW YORK (Reuters Health) – A normal coronary artery calcium (CAC) scan in middle-age appears to have a “warranty period” of about four years, during which the patient…
NEW YORK (Reuters Health) – With small breast cancers, doing complete axillary dissections only for positive sentinel lymph node biopsies (SNLB) yields the same 10-year survival – roughly…
NEW YORK (Reuters Health) – Use of insulin glargine or detemir rather than NPH insulin does not reduce the risk of ketoacidosis in children and adolescents with type…
Program OverviewThe Best Practice Series in Heart Failure is a series of 3-4 minute videos featuring top physicians discussing the best ways to diagnose and treat Heart Failure…
Program OverviewThe Best Practice Series in Heart Failure is a series of 3-4 minute videos featuring top physicians discussing the best ways to diagnose and treat Heart Failure…
NEW YORK (Reuters Health) – Injection of Macroplastique (Uroplasty), a urethral bulking agent, can improve female stress urinary incontinence for at least two years, new research shows. Exactly…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – Some patients with ocular hypertension are at low risk of progressing to open-angle glaucoma and don’t need treatment, research shows. But for patients…
